TMCnet News
Research and Markets: Diffuse Large B-Cell Lymphoma Pipeline Review, H1 2015 - Provides a Snapshot of the Global Therapeutic Landscape of Diffuse Large B-Cell LymphomaResearch and Markets (http://www.researchandmarkets.com/research/p7xnl2/diffuse_large) has announced the addition of the "Diffuse Large B-Cell Lymphoma - Pipeline Review, H1 2015" report to their offering. This report provides comprehensive information on the therapeutic development for Diffuse Large B-Cell Lymphoma, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Diffuse Large B-Cell Lymphoma and special features on late-stage and discontinued projects. This report features investigational drugs from across the globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from proprietary databases, Company/University websites, SEC (News - Alert) filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by this team. Scope
Reasons to buy
Companies Mentioned
For more information visit http://www.researchandmarkets.com/research/p7xnl2/diffuse_large View source version on businesswire.com: http://www.businesswire.com/news/home/20150813005474/en/ |